Latest news from Daxor Inc. on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/new-data-shows-heart-failure-treatment-guided-by-daxor-s-bva-100-lowers-hospital-length-of-stay-by-55/?sc=rsin /articles/new-data-shows-heart-failure-treatment-guided-by-daxor-s-bva-100-lowers-hospital-length-of-stay-by-55/?sc=rsin Mon, 03 Oct 2022 09:00:00 EST New data validate the benefits of the BVA-100 diagnostic blood volume measurement test in reducing hospital length of stay (LOS) for heart failure (HF) patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 - which brought together the world's leading experts in heart failure. Daxor Inc. /articles/new-data-shows-85-reduction-in-one-year-mortality-for-medicare-heart-failure-patients-with-bva-guided-care/?sc=rsin /articles/new-data-shows-85-reduction-in-one-year-mortality-for-medicare-heart-failure-patients-with-bva-guided-care/?sc=rsin Mon, 03 Oct 2022 08:40:00 EST New data validate the benefits of the BVA-100 blood volume measurement test for Medicare heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 - which brought together the world's leading experts in heart failure. Daxor Inc.